The predictive values of beta 1-adrenergic and M 2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure

European Journal of Heart Failure

Volumn 14, Issue 8, 2012, Pages 887-894

  Pei, Juanhui ^d   Li, Ning ^a   Chen, Jingzhou ^a   Li, Xian ^a   Zhang, Yinhui ^a   Wang, Zengwu ^a   Zhang, Ping ^b   Cao, Kejiang ^c   Pu, Jielin ^a  

^a FUWAI HOSPITAL   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d NONE

Author keywords

Autoantibody; Beta 1 adrenergic receptor; Chronic heart failure; M 2 muscarinic receptor; Sudden cardiac death

Indexed keywords

AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR AUTOANTIBODY; MUSCARINIC M2 RECEPTOR; MUSCARINIC M2 RECEPTOR AUTOANTIBODY; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SUDDEN DEATH; SURVIVAL; AGED; CARDIOMYOPATHY; CASE CONTROL STUDY; CONFIDENCE INTERVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; IMMUNOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY;

AGED; AUTOANTIBODIES; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DEATH, SUDDEN, CARDIAC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTOR, MUSCARINIC M2; RECEPTORS, ADRENERGIC, BETA-1; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84864430076     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfs082     Document Type: Article

References (34)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e46.
2. Ramani GV, Uber PA, Mehra MR. Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc 2010;85:180-195.
3. Linde C, Daubert C. Cardiac resynchronization therapy in patients with New York Heart Association class I and II heart failure: an approach to 2010. Circulation 2010;122:1037-1043.
4. Buxton AE, Lee KL, Hafley GE, Wyse DG, Fisher JD, Lehmann MH, Pires LA, Gold MR, Packer DL, Josephson ME, Prystowsky EN, Talajic MR; MUSTT Investigators. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation 2002;106:2466-2472.
5. Zimetbaum PJ, Buxton AE, Batsford W, Fisher JD, Hafley GE, Lee KL, O'Toole MF, Page RL, Reynolds M, Josephson ME. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation 2004;110:766-769.
6. European Heart Rhythm Association; Heart Rhythm Society, Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL; American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines.ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48:e247-e346.
7. Düngen HD, Platzeck M, Vollert J, Searle J, Müller C, Reiche J, Mehrhof F, Müller R, Mö ckel M. Autoantibodies against cardiac troponin I in patients with congestive heart failure. Eur J Heart Fail 2010;12:668-675.
8. Jahns R. Autoantibodies against cardiac troponin I: friend or foe? Eur J Heart Fail 2010;12:645-648.
9. Miao GB, Liu JC, Liu MB, Wu JL, Zhang G, Chang J, Zhang L.Autoantibody against b1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment. Eur J Clin Invest 2006;36:614-620.
10. Fu M, Matsui S. Is cardiomyopathy an autoimmune disease? Keio J Med 2002;51: 208-212.
11. Dö rffel WV, Felix SB, Wallukat G, Brehme S, Bestvater K, Hofmann T, Kleber FX, Baumann G, Reinke P. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 1997;95:1994-1997.
12. Felix SB, Staudt A, Dö rffel WV, Stangl V, Merkel K, Pohl M, Döcke WD, Morgera S, Neumayer HH, Wernecke KD, Wallukat G, Stangl K, Baumann G. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 2000;35:1590-1598.
13. Du XY, Schoemaker RG, Bos E, Saxena PR. Characterization of the positive and negative inotropic effects of acetylcholine in the human myocardium. Eur J Pharmacol 1995;284:119-127.
14. Ba A, Yoshikawa T, Fukuda Y, Sugiyama T, Shimada M, Akaishi M, Tsuchimoto K, Ogawa S, Fu M. Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J 2004;25:1108-1115.
15. Lazzerini PE, Capecchi PL, Guideri F, Acampa M, Selvi E, Bisogno S, Galeazzi M, Laghi-Pasini F. Autoantibody mediated cardiac arrhythmias: mechanisms and clinical implications. Basic Res Cardiol 2008;103:1-11.
16. Medei E, Pedrosa RC, Benchimol Barbosa PR, Costa PC, Hernández CC, Chaves EA, Linhares V, Masuda MO, Nascimento JH, Campos de Carvalho AC. Human antibodies with muscarinic activity modulate ventricular repolarization: basis for electrical disturbance. Int J Cardiol 2007;115:373-380.
17. Nussinovitch U, Katz U, Nussinovitch M, Nussinovitch N. Late ventricular potentials and QT dispersion in familial dysautonomia. Pediatr Cardiol 2009;30:747-751.
18. Fatkin D. Guidelines for the diagnosis and management of familial dilated cardiomyopathy. Heart Lung Circ 2007;16:19-21.
19. Iwata M, Yoshikawa T, Baba A, Anzai T, Mitamura H, Ogawa S. Autoantibodies against the second extracellular loop of b1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2001;37:418-424.
20. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F. Autoantibodies activating human b1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999;99:649-654.
21. Stö rk S, Boivin V, Horf R, Hein L, Lohse MJ, Angermann CE, Jahns R. Stimulating autoantibodies directed against the cardiac b1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J 2006;152:697-704.
22. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against b-adrenoreceptors in human dilated cardiomyopathy. Circ Res 1989;64: 97-103.
23. Freedman NJ, Lefkowitz RJ. Anti-b1-adrenergic receptor antibodies and heart failure: causation, not just correlation. J Clin Invest 2004;113:1379-1382.
24. Liang CS, Mao W, Liu J. Pro-apoptotic effects of antibeta1-adrenergic receptor antibodies in cultured rat cardiomyocytes: actions on endoplasmic reticulum and the prosurvival PI3K-Akt pathway. Autoimmunity 2008;41:434-441.
25. Felix SB, Staudt A. Immunoadsorption as treatment option in dilated cardiomyopathy. Autoimmunity 2008;41:484-489.
26. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F. Autoantibodies activating human b1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999;99:649-542.
27. Nikolaev VO, Boivin V, Stö rk S, Angermann CE, Ertl G, Lohse MJ, Jahns R. A novel fluorescence method for the rapid detection of functional b1-adrenergic receptor autoantibodies in heart failure. J Am Coll Cardiol 2007;50:423-431.
28. Deubner N, Berliner D, Schlipp A, Gelbrich G, Caforio AL, Felix SB, Fu M, Katus H, Angermann CE, Lohse MJ, Ertl G, Stö rk S, Jahns R; Etiology, Titre-Course, and Survival-Study Group. Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study. Eur J Heart Fail 2010;12:753-762.
29. Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ. Direct evidence for a b1-adrenergic receptor directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004;113:1419-1429.
30. Chiale PA, Ferrari I, Mahler E, Vallazza MA, Elizari MV, Rosenbaum MB, Levin MJ. Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 2001; 103:1765-1771.
31. Xiao H, Wang M, Du Y, Yuan J, Cheng X, Chen Z, Zou A, Wei F, Zhao G, Liao YH. Arrhythmogenic autoantibodies against calcium channel lead to sudden death in idiopathic dilated cardiomyopathy. Eur J Heart Fail 2011;13: 264-270.
32. Giménez LE, Hernández CC, Mattos EC, Brandão IT, Olivieri B, Campelo RP, Araújo-Jorge T, Silva CL, Campos de Carvalho AC, Kurtenbach E. DNA immunizations with M2 muscarinic and beta1 adrenergic receptor coding plasmids impair cardiac function in mice. J Mol Cell Cardiol 2005;38:703-714.
33. Fukuda Y, Miyoshi S, Tanimoto K, Oota K, Fujikura K, Iwata M, Baba A, Hagiwara Y, Yoshikawa T, Mitamura H, Ogawa S. Autoimmunity against the second extracellular loop of beta (1)-adrenergic receptors induces early afterdepolarization and decreases in Kchannel density in rabbits. J Am Coll Cardiol 2004; 43:1090-1100.
34. Lazzerini PE, Capecchi PL, Guideri F, Acampa M, Selvi E, Bisogno S, Galeazzi M, Laghi-Pasini F. Autoantibody mediated cardiac arrhythmias: mechanisms and clinical implications. Basic Res Cardiol 2008;103:1-11.